Reported Consolidated quarterly numbers for Vivimed Labs are:
Net Sales at Rs 36.51 crore in December 2024 down 11.94% from Rs. 41.46 crore in December 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 5.98 crore in December 2024 up 62.77% from Rs. 16.05 crore in December 2023.
EBITDA stands at Rs. 1.13 crore in December 2024 down 13.74% from Rs. 1.31 crore in December 2023.
Vivimed Labs shares closed at 4.95 on July 31, 2023 (NSE)
Story continues below Advertisement
| Vivimed Labs | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Dec'23 | | Net Sales/Income from operations | 36.51 | 24.77 | 41.46 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 36.51 | 24.77 | 41.46 | | EXPENDITURE | | Consumption of Raw Materials | 14.71 | 15.47 | 20.83 | | Purchase of Traded Goods | -- | -- | 0.63 | | Increase/Decrease in Stocks | 4.97 | -4.11 | 0.31 | | Power & Fuel | -- | -- | -- | | Employees Cost | 7.29 | 6.29 | 9.75 | | Depreciation | 6.62 | 4.10 | 4.70 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 8.47 | 7.76 | 8.67 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -5.56 | -4.74 | -3.43 | | Other Income | 0.07 | 0.03 | 0.04 | | P/L Before Int., Excpt. Items & Tax | -5.49 | -4.71 | -3.39 | | Interest | 0.48 | 0.43 | 13.21 | | P/L Before Exceptional Items & Tax | -5.98 | -5.14 | -16.60 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.98 | -5.14 | -16.60 | | Tax | -- | -- | -0.55 | | P/L After Tax from Ordinary Activities | -5.98 | -5.14 | -16.05 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.98 | -5.14 | -16.05 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -5.98 | -5.14 | -16.05 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.72 | -0.63 | -1.24 | | Diluted EPS | -0.70 | -0.60 | -1.20 | | EPS After Extra Ordinary | | Basic EPS | -0.72 | -0.63 | -1.24 | | Diluted EPS | -0.70 | -0.60 | -1.20 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
